Drug Trial Radar · NCT02177773
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
Last checked: Nov 20, 2026Latest source record: Nov 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
300
Actual
Start
Jun 23, 2014
Primary completion
Aug 7, 2017
Study completion Aug 7, 2017
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Peterson Family Foundation
- First posted
- Jun 30, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase I/II trial studies how well gallium Ga 68-DOTA-TOC positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) works in imaging patients with somatostatin receptor positive tumors. Gallium Ga 68-DOTA-TOC binds to somatostatin receptor positive tumors and can be seen using a PET scan. A PET scan uses a special camera to detect energy given off from gallium Ga 68-DOTA-TOC, to make detailed pictures of areas where material accumulates in the body. Diagnostic procedures, such as gallium Ga 68-DOTA-TOC PET/CT or PET/MRI, may help find and diagnose somatostatin receptor positive tumors and help plan the best treatment.
Conditions
- Neuroendocrine Tumor
- Paraganglioma
- Carcinoid Tumors
- Neuroblastoma
Interventions
Computed Tomography (CT)Procedure
Undergo Gallium Ga 68-DOTA-TOC PET/CT
Gallium Ga 68-EdotreotideDrug
Given Intravenously (IV) before imaging
Magnetic Resonance Imaging (MRI)Procedure
Undergo gallium Ga 68-DOTA-TOC PET/MRI
Positron Emission Tomography (PET)Procedure
Undergo gallium Ga 68-DOTA-TOC PET in combination with CT or MRI
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Lesions as Determined by Gallium Ga 68-DOTA-TOC Positron Emission Tomography (PET) ImagingTime frame: 1 day
- Standardized Uptake Value Maximum (SUVmax)Time frame: 1 day
- Inter-reader VariabilityTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.